학술논문
Efficacy and safety results of FGFR1-3 inhibitor, tinengotinib, as monotherapy in patients with advanced, metastatic cholangiocarcinoma: Results from phase II clinical trial.
Document Type
Article
Author
Javle, Milind M.; Mahipal, Amit; Kankeu Fonkoua, Lionel Aurelien; Fountzilas, Christos; Li, Daneng; Pelster, Meredith; Liao, Chih-Yi; Richards, Donald A.; Deming, Dustin A.; Younes, Mohamad Ahmad; Mantry, Parvez; Cohn, Allen Lee; Kingsley, Ed; Fan, Jean; Peng, Peng; Sun, Caixia; Wang, Hui; Hennessy, Katie; Shan, Yujun; Wu, Frank
Source
Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p434-434, 151p
Subject
Language
ISSN
0732183X